Download Android Apps and Games
AppBrain
  • Apps
  • Apps being viewed right now Trending apps today Most popular apps All-time most downloaded apps Top rated apps
  • Intelligence ▾
    Intelligence overview → Track any Android app or your whole market
    Track & analyze
    Keyword Tracker & OptimizerTrack & improve Play rankings App Performance ReportOne-off PDF for any app StatisticsFree Android & Play market stats
    Promote your app
    Featured Apps App Links
  • Intelligence
  • Pricing
  • Dashboard
  • Sign up
  • Log in
Android Apps > Medical > ADR PvPI
ADR PvPI icon

ADR PvPI

1.9.1
Pharmacovigilance Programme of India (PvPI)
0.00
0 reviews
10,000+
Downloads
Free

Adverse Drug Reaction Reporting Application.

This app is currently not available on Google Play.

Try these apps instead

Yellow Card Scheme icon Yellow Card Scheme
Medicines & Healthcare products Regulatory Agency
4.1
Free
50,000+
Nurse’s Drug Handbook icon Nurse’s Drug Handbook
MobiSystems
4.3
Free
500,000+
Uptodate Lexidrug icon Uptodate Lexidrug
Wolters Kluwer Health UpToDate
3.6
Free
1,000,000+
100 Essential drugs icon 100 Essential drugs
Liixuos
4.0
Free
5,000+
Drug Center - Pediatric Oncall icon Drug Center - Pediatric Oncall
Pediatric Oncall
5.0
Free
10,000+
Drugs & Drugs icon Drugs & Drugs
Drugs & Drugs
4.1
Free
100,000+
Medisafe Pill & Med Reminder icon Medisafe Pill & Med Reminder
Medisafe®
4.5
Free
5,000,000+
ADR Dangerous Goods (ADR 2025) icon ADR Dangerous Goods (ADR 2025)
MangoData
3.5
Free
100,000+

About ADR PvPI

ADR PvPI was a medical app developed by Pharmacovigilance Programme of India (PvPI). It was removed from Google Play Oct 22, 2024 and is no longer available for download.

Download Statistics

ADR PvPI had been downloaded 23 thousand times before it became unavailable.

User Ratings

The app had no ratings.

App Information

ADR PvPI was free to download. The APK download size was 2.90 MB. The last available version was 1.9.1. The last update was on November 17, 2021.

Technical Requirements

ADR PvPI required Android 4.0.3+ or higher. The app had a content rating of Everyone. The app had been available on Google Play July 2017.

Description
PvPI adverse drug reaction reporting android application. Using PvPI adverse reporting android application Healthcare professional or consumers can instantly report any suspected Adverse Drug Reaction to PvPI from any part of india.

The Pharmacovigilance Program of India (PvPI) was launched with a broad objective to safe guard the health of 1.27 billion people of India. Adverse drug Reactions (ADRs) are reported from all over the country to PvPI, which also work in collaboration with the global ADR monitoring centre (WHO-UMC), Sweden to contribute in the global ADRs data base. PvPI monitors the ADRs among Indian population and helps the regulatory authority of India (CDSCO) in taking decision for safe use of medicines. I invite all the health care professionals and patients/consumers to join us in our mission to promote patient safety.

Recent changes:
Thanks for choosing ADR PvPI for ADR reporting! This release includes stability and performance improvements.
Show more Show less

More data about ADR PvPI

Price Free to download
Total downloads 23 thousand
Rating No ratings
Version 1.9.1
APK size 2.90 MB
Number of libraries 6
Designed for Android 4.0.3+
Suitable for Everyone
Ads NO ads

App Performance Report

Get a detailed PDF report for ADR PvPI with download trends, rating history, and key performance statistics — useful for competitive research or tracking your own app. Learn more

Get PDF Report — $29

Downloads over time

ADR PvPI has been downloaded 23 thousand times.

Changelog of ADR PvPI

Show changelog

Developer information for Pharmacovigilance Programme of India (PvPI)

Pharmacovigilance Programme of India (PvPI)

Address: N/A

Share ADR PvPI

Comments on ADR PvPI for Android

★★★★★ New Revolution in India to report ADRs as other countries (USA, JAPAN AND EUROPE) helps to monitor patient's safety...
★★★★★ Nice aap and great initiative by pvpi. Should add some features which show drugs having serious adr and drug related problems. Update drug withdrawn from market due to adr
★★★★★ I am Dr. Sumeet I sent a report in test mode. It got successfully reported. I received an email too. But the information I filled was not into the specific columns in the PDF attachments. The concomitant drugs were in the column of Other relevant history. Also, there is no provision of non-serious option. Add months for age The suspected drug Ranitidine was also repeated in the concomitant drug column. Kindly provide an additional input source for the concomitant medication as provided for the suspected medicines as given in the vigiflow site input.
★★☆☆☆ Why we are not receiving the email or reference mail after reporting ADR???
★★☆☆☆ I have been using this app form August. I got to update ADRs only on August and September. In the end of September to now... I'm not getting the email (PDF) which I'm registering in the ADR PvPI. Please could you rectify this issue... I'm working as a Clinical Pharmacologist. As I am monitoring the ADR. So please look into the issues.
★★☆☆☆ Many details asked are very much specific which a layman patient can't give. And kept them as mandatory for submission which should be optional. Not user-friendly for a layman non-scientific person, which it should be.

Technologies used by ADR PvPI

ADR PvPI is requesting 4 permissions and is using 6 libraries.
Show details
Yellow Card Scheme icon Yellow Card Scheme
Nurse’s Drug Handbook icon Nurse’s Drug Handbook
Uptodate Lexidrug icon Uptodate Lexidrug
100 Essential drugs icon 100 Essential drugs
Drug Center - Pediatric Oncall icon Drug Center - Pediatric Oncall
Drugs & Drugs icon Drugs & Drugs
Medisafe Pill & Med Reminder icon Medisafe Pill & Med Reminder
ADR Dangerous Goods (ADR 2025) icon ADR Dangerous Goods (ADR 2025)

Back to top
AppBrain Intelligence premium content

Subscribe now to get full and unlimited access to AppBrain Intelligence. You'll have access to:

  • App Intelligence dashboard (performance timeline, competitor comparison, country rankings, insight cards)
  • Detailed ranking data per app
  • Full timeline per developer
  • Device market shares data per country
1 Month

$75/mo
(billed every month)

SAVE 0%
Subscribe
3 Months

$65/mo
($195 billed every 3 months)

SAVE 13%
Subscribe
1 Year

$57.50/mo
($690 billed every year)

SAVE 23%
Subscribe
Each subscription will automatically renew 3 days before the expiration date for the same time period. Subscriptions can be cancelled at any time before the renewal.

AppBrain is a directory focused on discovering great apps and games. We give statistics, rankings and search options that Google Play and the App Store don't have. All trademarks are owned by their respective owners. AppBrain doesn't offer APKs or binaries, and always lets users install the official version from Google Play or the App Store.

More apps

  • Top Android apps being viewed
  • Ferrio: Unusual holidays for Android
  • View Tradeinn: Sports Store
  • Kid Mode: Free Learning Games

Android Statistics

  • Android statistics
  • Google Play Developer stats
  • Trending Android Apps
  • Top popular Apps
  • Buy the best Android phone

About AppBrain

  • Contact
  • Privacy
  • Documentation
  • DMCA takedowns
  • Articles
  • Blog
  • Android app Install tracking and attribution options for the AppBrain ad network
© 2010-2026 - AppBrain